US Medical Diagnostics Market
Dublin, Jan. 23, 2023 (GLOBE NEWSWIRE) — The “US Medical Diagnostics Market (Product Type, End User & Region): Insights and Forecasts with Potential Impact of COVID-19 (2023-2027)” report has been added to the ResearchAndMarkets.com’s offering.
The US medical diagnostics market is expected to reach $41.95 billion by 2027, witnessing growth at a CAGR of 4.62%, during the period 2023-2027.
Factors such as the growing geriatric population, increasing burden of chronic diseases, increasing access to electronic health record (EHR) systems, rising healthcare costs and expanding Urbanization will drive the growth of the market.
However, market growth will be challenged due to shortage of trained laboratory technicians, high cost of molecular diagnostics and in vitro diagnostic equipment and challenges in pre-market approval (PMA) & IVD . A few notable trends include the adoption of health-related devices such as wearables, the rise of various infectious diseases, the increasing integration of Artificial Intelligence and the growing awareness of the special medicine.
The US medical diagnostics market has been segmented on the basis of type, product type, and end user. In terms of type, the market can be divided into in-vitro diagnostics and in-vivo diagnostics. The US in-vitro diagnostics market is further segmented on the basis of product type and application.
Based on product type, the US medical diagnostics market can be segmented into reagents, hardware, and software & services. However, the market can be segmented into hospitals, medical centers and Physician Office Labs (POLs) & others, based on the end user.
The fastest growing regional market is the southern region of the United States, due to the increasing prevalence of chronic and infectious diseases in the population, increasing automation in laboratories and hospitals, increasing patient awareness of personalized medicine and a shift in choice to point-of-care (POC) testing.
Scope of the report
The report provides a comprehensive analysis of the US medical diagnostics market segmented on the basis of type, product type, end user, and region.
Major regional and country markets (South, Mid-Western, West and North-East) are analyzed.
Market dynamics such as growth drivers, market trends and challenges are analyzed in depth.
Company profiles of major players (Roche Holding AG, Abbott Laboratories, Danaher Corporation, Becton, Dickinson and Company, Quest Diagnostics Inc., and BioMerieux SA) are also presented in detail.
2023 – 2027
Estimated market price (USD) in 2023
Market value (USD) in 2027
Annual growth rate
Key Topics Covered:
1. Market Overview
2. Impact of COVID-19
22.1 Increase in Demand for Medical Diagnostics
2.2 Increase in government spending on health
2.3 Advances in Diagnostics Based on Reverse-Transcription Polymerase Chain Reaction (RT-PCR)
3. The US Market Analysis
3.1 US Medical Diagnostics Market by Value
3.2 US Medical Diagnostics Market Forecast by Price
3.3 US Medical Diagnostics Market by Type
3.3.1 United States In-Vitro Diagnostics Market by Value
3.3.2 United States In-Vitro Diagnostics Market Forecast by Value
3.3.3 United States In-Vitro Diagnostics Market by Product Type
3.3.4 United States In-Vitro Diagnostics Product Type Market by Value
3.3.5 US In-Vitro Diagnostics Product Type Market Forecast by Value
3.3.6 United States In-Vitro Diagnostics Market by Application
3.3.7 United States In-Vitro Diagnostic Applications Market by Value
3.3.8 United States In Vivo Diagnostics Market by Value
3.3.9 US In Vivo Diagnostics Market Forecast by Value
3.4 US Medical Diagnostics Market by Product Type
3.4.1 US Medical Care Product Type Market by Value
3.4.2 US Medical Care Product Type Market by Value
3.5 US Medical Diagnostics Market by End User
3.5.1 US Medical Devices End User Market by Value
3.5.2 US Medical Devices End User Market Forecast by Value
3.6 US Medical Diagnostics Market by Region
4. Regional market analysis
4.1 South US
4.1.1 South US Medical Diagnostics Market Estimates by Value
4.2.1 Midwest Medical Diagnostics Market Estimates by Value
4.3 Western United States
4.3.1 Western United States Medical Diagnostics Market by Value
4.4 Northeast United States
4.4.1 Northeast United States Medical Diagnostics Market by Value
5. Market dynamics
5.1 Growth drivers
5.1.1 The population giving birth is increasing
5.1.2 The burden of chronic diseases is increasing
5.1.3 Increasing access to electronic health record (EHR) systems.
5.1.4 Increase in health costs
5.1.5 Urban expansion
5.2 Major trends and developments
5.2.1 Construction of health-related equipment such as wearables
5.2.2 Outbreaks of various infectious diseases
5.2.3 Increasing integration with artificial intelligence
5.2.4 Increasing awareness of personalized medicine
5.3.1 Shortage of Trained Laboratory Technicians
5.3.2 Cost of Advanced Molecular Diagnostics & In-Vitro Diagnostic Tools
5.3.3 Pre-market approval (PMA) challenges & IVD labeling requirements
6. Company information
6.1 Roche Holding AG
6.1.1 Business overview
6.2 Abbott Laboratories
6.2.1 Business Overview
6.3 Danaher Corporation
6.3.1 Business Overview
6.4 Becton, Dickinson and Company
6.4.1 Business Overview
6.5 Quest Diagnostics Inc.
6.5.1 Business Overview
6.6 BioMerieux SA
6.6.1 Business Overview
For more information on this report, visit https://www.researchandmarkets.com/r/24gibd
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager email@example.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900